
Zorex Pharma Private Limited
Pharmaceutical trading and distribution, specializing in PCD franchise opportunities.
Pharmaceutical trading and distribution, specializing in PCD franchise opportunities.
Zorex Pharma Private Limited (ZPPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 May 1996 and has a history of 28 years and 11 months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.74 M.
The company currently has active open charges totaling ₹4.00 M. The company has closed loans amounting to ₹3.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhupendra Shah, Viral Shah, and Jigar Shah serve as directors at the Company.
Ahmedabad, Gujarat, India
+91-XXXXXXXXXX
U24231GJ1996PTC029593
029593
Private Limited Indian Non-Government Company
13 May 1996
30 Sep 2024
31 Mar 2024
Unlisted
Roc Ahmedabad
Zorex Pharma Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Nutraceuticals & Dietary Supplements, Mineral Supplement, Cardiovascular Drugs & Medication, Antidiabetic Medicine, Vitamin Tablets & Capsules, Pain Relief Drugs & Pharmaceuticals.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bhupendra Shah ![]() | Director | 09-Jan-1997 | Current |
Viral Shah ![]() | Director | 08-Feb-2010 | Current |
Jigar Shah ![]() | Director | 08-Feb-2010 | Current |
Zorex Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.47% increase. The company also saw a substantial improvement in profitability, with a 761.12% increase in profit. The company's net worth moved up by a moderate rise of 8.88%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Zorex Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
₹4.00 M
₹31.45 M
Date | Lender | Amount | Status |
---|---|---|---|
02 Sep 2022 | The Kalupur Commercial Co-Operative Bank Limited | ₹4.00 M | Open |
22 Apr 2013 | The Kaluput Commercial Co Op Bank Ltd | ₹6.95 M | Satisfied |
23 Apr 2010 | The Kalupur Commercial Co. Op. Bank Ltd. | ₹2.00 M | Satisfied |
13 Aug 2007 | The Kalupur Commercial Co-Op Bank Ltd. | ₹8.40 M | Satisfied |
07 Aug 2007 | The Kalupur Commercial Co.Op. Bank Ltd. | ₹2.00 M | Satisfied |
Unlock and access historical data on people associated with Zorex Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Zorex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zorex Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Zorex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Zorex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
A charge registered on 22 Apr 2013 via Charge ID 10424252 with The Kaluput Commercial Co Op Bank Ltd was fully satisfied on 03 Oct 2022.
A charge with The Kalupur Commercial Co-Operative Bank Limited amounted to Rs. 4.00 M with Charge ID 100610867 was registered on 02 Sep 2022.
A charge with The Kaluput Commercial Co Op Bank Ltd of Rs. 6.95 M registered on 22 Apr 2013 with Charge ID 10424252 was modified on 27 Apr 2015.
A charge registered on 23 Apr 2010 via Charge ID 10217712 with The Kalupur Commercial Co. Op. Bank Ltd. was fully satisfied on 23 Apr 2013.
Zorex Pharma Private Limited was incorporated on 13 May 1996.
The authorized share capital of Zorex Pharma Private Limited is ₹ 5.00 M and paid-up capital is ₹ 2.74 M.
Currently 3 directors are associated with Zorex Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Zorex Pharma Private Limited is 12 Visat Apartments Behind Ashima Towers Nr. Sandesh Press Bodakdev, India, Ahmedabad, Gujarat, 380015.
The corporate identification number (CIN) of Zorex Pharma Private Limited is U24231GJ1996PTC029593 and the company number is 029593 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Zorex Pharma Private Limited has risen by 40.47%.
The financial reports for the fiscal year 2023 indicates that The net worth of Zorex Pharma Private Limited has experienced an upsurge of 8.88%.
As per the financial statements for fiscal Year 2023, The total open charges for Zorex Pharma Private Limited amount to ₹ 4.00 M.
The most recent Balance Sheet for Zorex Pharma Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
SS
SS
DS
PS